Elma is an accomplished scientist with more than 15 years of drug development experience. Prior to joining Entact Bio, Elma was at Invitrogen, and most recently at Merck where she contributed throughout the drug discovery continuum. She has expertise in cell based assay development to support hit-to-lead and lead optimization, MoA interrogation, as well as in the development of complex translational models aimed at bridging the gap to the clinic.
Elma received her M.S. in Pharmaceutical Sciences from Northeastern University, and her B.S. in Biology from Clark University.
In her free time Elma loves to travel the world, hike, bike and play tennis.